Solventum (SOLV) Competitors $68.39 +1.34 (+2.00%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends SOLV vs. ZBH, SNN, PEN, GKOS, BLCO, INSP, PRCT, AXNX, NVST, and NARIShould you be buying Solventum stock or one of its competitors? The main competitors of Solventum include Zimmer Biomet (ZBH), Smith & Nephew (SNN), Penumbra (PEN), Glaukos (GKOS), Bausch + Lomb (BLCO), Inspire Medical Systems (INSP), PROCEPT BioRobotics (PRCT), Axonics (AXNX), Envista (NVST), and Inari Medical (NARI). These companies are all part of the "medical equipment" industry. Solventum vs. Zimmer Biomet Smith & Nephew Penumbra Glaukos Bausch + Lomb Inspire Medical Systems PROCEPT BioRobotics Axonics Envista Inari Medical Solventum (NYSE:SOLV) and Zimmer Biomet (NYSE:ZBH) are both large-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, risk, community ranking, media sentiment, valuation, institutional ownership, profitability, analyst recommendations and dividends. Do insiders and institutionals hold more shares of SOLV or ZBH? 88.9% of Zimmer Biomet shares are owned by institutional investors. 0.7% of Zimmer Biomet shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Which has better earnings & valuation, SOLV or ZBH? Zimmer Biomet has higher revenue and earnings than Solventum. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSolventumN/AN/AN/AN/AN/AZimmer Biomet$7.39B2.94$1.02B$5.2620.78 Does the MarketBeat Community favor SOLV or ZBH? Zimmer Biomet received 898 more outperform votes than Solventum when rated by MarketBeat users. Likewise, 67.24% of users gave Zimmer Biomet an outperform vote while only 5.88% of users gave Solventum an outperform vote. CompanyUnderperformOutperformSolventumOutperform Votes15.88%Underperform Votes1694.12% Zimmer BiometOutperform Votes89967.24% Underperform Votes43832.76% Do analysts prefer SOLV or ZBH? Solventum presently has a consensus target price of $68.00, indicating a potential downside of 0.57%. Zimmer Biomet has a consensus target price of $123.22, indicating a potential upside of 12.73%. Given Zimmer Biomet's stronger consensus rating and higher possible upside, analysts clearly believe Zimmer Biomet is more favorable than Solventum.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Solventum 1 Sell rating(s) 8 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00Zimmer Biomet 2 Sell rating(s) 12 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.20 Is SOLV or ZBH more profitable? Zimmer Biomet has a net margin of 14.27% compared to Solventum's net margin of 0.00%. Zimmer Biomet's return on equity of 12.95% beat Solventum's return on equity.Company Net Margins Return on Equity Return on Assets SolventumN/A N/A N/A Zimmer Biomet 14.27%12.95%7.55% Does the media prefer SOLV or ZBH? In the previous week, Zimmer Biomet had 2 more articles in the media than Solventum. MarketBeat recorded 16 mentions for Zimmer Biomet and 14 mentions for Solventum. Zimmer Biomet's average media sentiment score of 1.05 beat Solventum's score of 0.88 indicating that Zimmer Biomet is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Solventum 7 Very Positive mention(s) 0 Positive mention(s) 6 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Zimmer Biomet 11 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryZimmer Biomet beats Solventum on 13 of the 13 factors compared between the two stocks. Ad DTIDownload Our Tesla Ebook For FreeLike many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.To claim your copy free of charge simply follow this link. Get Solventum News Delivered to You Automatically Sign up to receive the latest news and ratings for SOLV and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SOLV vs. The Competition Export to ExcelMetricSolventumSurgical & medical instruments IndustryMedical SectorNYSE ExchangeMarket Cap$11.81B$4.42B$5.06B$19.88BDividend YieldN/A41.17%5.18%3.52%P/E RatioN/A24.81126.3142.94Price / SalesN/A47.031,178.7419.18Price / CashN/A51.8733.8617.86Price / BookN/A4.974.685.52Net IncomeN/A$13.76M$119.54M$986.45M7 Day Performance0.68%-1.08%-1.83%0.45%1 Month Performance-6.44%0.58%-3.60%1.05%1 Year PerformanceN/A50.91%31.91%24.67% Solventum Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SOLVSolventum1.804 of 5 stars$68.39+2.0%$68.00-0.6%N/A$11.58BN/A0.0022,000ZBHZimmer Biomet4.6279 of 5 stars$109.31-1.5%$123.22+12.7%-2.8%$22.09B$7.39B20.7818,000Positive NewsSNNSmith & Nephew2.1198 of 5 stars$25.22-1.2%N/A-1.4%$11.15B$5.55B0.0018,452PENPenumbra4.3167 of 5 stars$239.20+0.9%$227.92-4.7%+1.6%$9.18B$1.16B278.144,200Analyst ForecastInsider TradeGKOSGlaukos3.8428 of 5 stars$141.44-1.9%$134.55-4.9%+121.3%$7.80B$360.35M-46.83780Positive NewsBLCOBausch + Lomb2.3996 of 5 stars$19.39-0.8%$20.91+7.8%+23.2%$6.88B$4.15B0.0013,300INSPInspire Medical Systems4.9104 of 5 stars$184.88+5.0%$233.58+26.3%+29.2%$5.28B$624.80M172.781,011Analyst UpgradePositive NewsGap UpPRCTPROCEPT BioRobotics1.5867 of 5 stars$92.70-0.9%$89.50-3.5%+180.7%$4.88B$136.19M0.00626AXNXAxonics3.2587 of 5 stars$70.98flat$71.00+0.0%N/A$3.63B$366.38M-591.45610News CoverageNVSTEnvista3.6426 of 5 stars$20.37+0.5%$20.71+1.7%-14.3%$3.49B$2.57B-2.6212,800NARIInari Medical3.2625 of 5 stars$49.00-3.9%$58.89+20.2%-15.9%$2.98B$493.63M0.001,300Insider TradePositive News Related Companies and Tools Related Companies ZBH Alternatives SNN Alternatives PEN Alternatives GKOS Alternatives BLCO Alternatives INSP Alternatives PRCT Alternatives AXNX Alternatives NVST Alternatives NARI Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:SOLV) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Solventum Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Solventum With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
